Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Beijing Friendship Hospital
With
The Second Affiliated Hospital of Chongqing Medical University
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Age over 18 years old, male or female;
2. patients with clinically diagnosed chronic liver disease, including hepatitis C virus (HCV) infection, hepatitis B virus (HBV) infection, fatty liver disease, autoimmune liver disease, and alcoholic liver disease \*;
3. Liver stiffness measurement (LSM) ≥10kPa during screening or within one month before screening \[4\];
4. able to communicate well with the investigators, understand and comply with the requirements of the study;
5. Informed consent was signed voluntarily.
You may not be if
1. alanine aminotransferase (ALT) or aspartate aminotransferase (AST) ≥250 U/L;
2. complicated with jaundice (serum total bilirubin ≥50 μmol/L);
3. complicated with important organ diseases (except liver) or serious systemic diseases (such as malignant tumors and HIV);
4. after liver transplantation or TIPS;
5. after splenectomy, splenic embolization or other portasystemic shunts;
6. patients with moderate-to-large amount of ascites;
7. unstable condition in the acute stage of esophageal variceal bleeding;
8. combined with liver malignant tumors;
9. patients with non-cirrhotic portal hypertension, Budd-Chiari syndrome and other hepatic vascular diseases; Acute or chronic portal vein thrombosis;
10. unhealed wounds or scars in the left abdomen were not suitable for ultrasound examination;
11. pregnant women;
12. Other conditions judged by the investigators as not suitable for participating in the study.
Clareo Health | Clinical Trial to Evaluate the Effectiveness of Liver Shear Wave Quantization Detector Spleen Stiffness Value in the Diagnosis of Esophageal Varices
